Table 2.
ΔeGFRcrea ≤–3.01 ml/min/1.73 m2 (n = 714) |
ΔeGFRcys ≤–3.01 ml/min/1.73 m2 (n = 1,083) |
|||||
---|---|---|---|---|---|---|
events |
OR (95% CI) |
p value |
events |
OR (95% CI) |
p value | |
Age |
||||||
65–69 years | 228 | 1.00 (ref.) | 351 | 1.00 (ref.) | ||
70–74 years | 232 | 1.59 (1.28, 1.97) | 0.002 | 383 | 1.38 (1.16, 1.65) | <0.001 |
75–79 years | 153 | 2.00 (1.56, 2.57) | <0.001 | 220 | 1.62 (1.31, 1.99) | <0.001 |
≥80 years | 101 | 3.90 (2.88, 5.28) | <0.001 | 141 | 2.96 (2.28, 3.84) | <0.001 |
African-American | 1.22 (0.96, 1.54) | 0.104 | 1.19 (0.97, 1.45) | 0.11 | ||
Male sex | 0.51 (0.41, 0.62) | <0.001 | 1.02 (0.87, 1.21) | 0.80 |
Odds ratios adjusted for prevalent cardiovascular disease and kidney risk factors (hypertension, diabetes, smoking, HDL, LDL, baseline kidney measure)